1. Home
  2. RELL vs FATE Comparison

RELL vs FATE Comparison

Compare RELL & FATE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RELL
  • FATE
  • Stock Information
  • Founded
  • RELL 1947
  • FATE 2007
  • Country
  • RELL United States
  • FATE United States
  • Employees
  • RELL N/A
  • FATE N/A
  • Industry
  • RELL Electronic Components
  • FATE Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • RELL Technology
  • FATE Health Care
  • Exchange
  • RELL Nasdaq
  • FATE Nasdaq
  • Market Cap
  • RELL 127.4M
  • FATE 133.0M
  • IPO Year
  • RELL N/A
  • FATE 2013
  • Fundamental
  • Price
  • RELL $8.78
  • FATE $1.30
  • Analyst Decision
  • RELL
  • FATE Hold
  • Analyst Count
  • RELL 0
  • FATE 8
  • Target Price
  • RELL N/A
  • FATE $4.14
  • AVG Volume (30 Days)
  • RELL 36.3K
  • FATE 1.7M
  • Earning Date
  • RELL 07-23-2025
  • FATE 05-13-2025
  • Dividend Yield
  • RELL 2.71%
  • FATE N/A
  • EPS Growth
  • RELL N/A
  • FATE N/A
  • EPS
  • RELL N/A
  • FATE N/A
  • Revenue
  • RELL $204,394,000.00
  • FATE $13,335,000.00
  • Revenue This Year
  • RELL $9.48
  • FATE N/A
  • Revenue Next Year
  • RELL $4.10
  • FATE N/A
  • P/E Ratio
  • RELL N/A
  • FATE N/A
  • Revenue Growth
  • RELL N/A
  • FATE 105.85
  • 52 Week Low
  • RELL $7.57
  • FATE $0.66
  • 52 Week High
  • RELL $15.51
  • FATE $5.92
  • Technical
  • Relative Strength Index (RSI)
  • RELL 45.20
  • FATE 57.89
  • Support Level
  • RELL $8.87
  • FATE $1.21
  • Resistance Level
  • RELL $9.26
  • FATE $1.38
  • Average True Range (ATR)
  • RELL 0.22
  • FATE 0.12
  • MACD
  • RELL 0.03
  • FATE 0.02
  • Stochastic Oscillator
  • RELL 10.67
  • FATE 82.36

About RELL Richardson Electronics Ltd.

Richardson Electronics Ltd provides engineered solutions, power grid, and microwave tubes and related consumables, power conversion, RF and microwave components, high-value flat panel detector solutions, replacement parts, tubes, and service training for diagnostic imaging equipment and customized display solutions. Its products have applications in alternative energy, healthcare, aviation, broadcast, communications, industrial, marine, medical, military, scientific, and semiconductor markets. The company segments include PMT (Power and Microwave Technologies Group), Canvys, (Green Energy Solutions) GES, and Healthcare reportable segments. The company derives the majority of its revenues from the PMT segment.

About FATE Fate Therapeutics Inc.

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.

Share on Social Networks: